Metagenomi (MGX) News Today $2.33 +0.42 (+21.99%) Closing price 04:00 PM EasternExtended Trading$2.44 +0.11 (+4.72%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Millennium Management LLCJune 15, 2025 | marketbeat.comInsider Selling: Metagenomi, Inc. (NASDAQ:MGX) CEO Sells 10,785 Shares of StockJune 10, 2025 | insidertrades.comMetagenomi, Inc. (NASDAQ:MGX) CEO Sells $18,873.75 in StockJune 9, 2025 | marketbeat.comMetagenomi, Inc. (NASDAQ:MGX) Short Interest Down 18.9% in MayJune 3, 2025 | marketbeat.comCitadel Advisors LLC Decreases Position in Metagenomi, Inc. (NASDAQ:MGX)June 2, 2025 | marketbeat.comNorthern Trust Corp Raises Position in Metagenomi, Inc. (NASDAQ:MGX)May 31, 2025 | marketbeat.comHC Wainwright Analysts Cut Earnings Estimates for MetagenomiMay 30, 2025 | marketbeat.comQ1 Earnings Forecast for Metagenomi Issued By HC WainwrightMay 29, 2025 | marketbeat.comMetagenomi, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To KnowMay 16, 2025 | finance.yahoo.com2MGX : Demystifying Metagenomi: Insights From 4 Analyst ReviewsMay 15, 2025 | benzinga.comMetagenomi Reports Promising Hemophilia A Study ResultsMay 14, 2025 | tipranks.comMetagenomi, Inc.: Metagenomi Reports Business Updates and First Quarter 2025 Financial ResultsMay 14, 2025 | finanznachrichten.deMetagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025May 14, 2025 | globenewswire.comMetagenomi Reports Business Updates and First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.comMetagenomi (MGX) Projected to Post Quarterly Earnings on TuesdayMay 8, 2025 | marketbeat.comMetagenomi to Present at Upcoming Scientific MeetingsMay 2, 2025 | globenewswire.comGeode Capital Management LLC Has $2.12 Million Stock Position in Metagenomi, Inc. (NASDAQ:MGX)May 2, 2025 | marketbeat.comNorges Bank Acquires New Holdings in Metagenomi, Inc. (NASDAQ:MGX)April 14, 2025 | marketbeat.comMetagenomi Leads The Charge With These 3 Penny StocksApril 10, 2025 | uk.finance.yahoo.comMetagenomi price target lowered to $7 from $14 at H.C. WainwrightApril 4, 2025 | markets.businessinsider.comMetagenomi, Inc. Common Stock (MGX) Latest After Hours TradesMarch 31, 2025 | nasdaq.comBiotech stocks slide as Marks resignation seen being negative for sectorMarch 31, 2025 | markets.businessinsider.comAnalysts Issue Forecasts for Metagenomi FY2025 EarningsMarch 28, 2025 | marketbeat.comBullish: Analysts Just Made A Significant Upgrade To Their Metagenomi, Inc. (NASDAQ:MGX) ForecastsMarch 27, 2025 | uk.finance.yahoo.comMetagenomi (NASDAQ:MGX) Given New $20.00 Price Target at Wells Fargo & CompanyMarch 19, 2025 | marketbeat.comMetagenomi, Inc.: Metagenomi Reports Business Updates and Full Year 2024 Financial ResultsMarch 19, 2025 | finanznachrichten.deMetagenomi (MGX) Expected to Announce Earnings on WednesdayMarch 19, 2025 | marketbeat.comMetagenomi Faces Legal Battle Over Alleged Misleading Statements in Moderna CollaborationMarch 19, 2025 | tipranks.comMetagenomi, Inc. Reports 2024 Financial Results and Pipeline ProgressMarch 18, 2025 | tipranks.comMetagenomi files $250M mixed securities shelfMarch 18, 2025 | markets.businessinsider.comMetagenomi (NASDAQ:MGX) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPSMarch 18, 2025 | marketbeat.comMetagenomi Reports 2024 Financial Results and UpdatesMarch 17, 2025 | tipranks.comMetagenomi Reports Business Updates and Full Year 2024 Financial ResultsMarch 17, 2025 | globenewswire.comMetagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) SystemsMarch 13, 2025 | globenewswire.comThis Emirati Prince Controls Four Times Elon Musk's Wealth and He’s Going All-In on AIFebruary 27, 2025 | msn.comGood Life Advisors LLC Acquires New Shares in Metagenomi, Inc. (NASDAQ:MGX)February 21, 2025 | marketbeat.comMetagenomi, Inc. (NASDAQ:MGX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesFebruary 18, 2025 | marketbeat.comShort Interest in Metagenomi, Inc. (NASDAQ:MGX) Rises By 21.7%February 16, 2025 | marketbeat.comPeapod Lane Capital LLC Takes $1.27 Million Position in Metagenomi, Inc. (NASDAQ:MGX)February 13, 2025 | marketbeat.comMetagenomi to Present at TD Cowen's 45th Annual Health Care ConferenceFebruary 11, 2025 | globenewswire.comTotus Medicines Appoints Simon Harnest As CFOJanuary 28, 2025 | markets.businessinsider.comNeutral On Metagenomi's Promising Yet Highly Speculative Gene Editing PotentialJanuary 28, 2025 | seekingalpha.comBrokerages Set Metagenomi, Inc. (NASDAQ:MGX) Price Target at $16.67January 27, 2025 | marketbeat.comMetagenomi, Inc. (NASDAQ:MGX) Given Consensus Recommendation of "Moderate Buy" by AnalystsJanuary 24, 2025 | marketbeat.comPromising Outlook for Metagenomi, Inc.: Strategic Collaborations and Technological Advancements Drive Buy RatingJanuary 17, 2025 | markets.businessinsider.comMetagenomi advances gene editing therapies into 2025January 16, 2025 | msn.comMetagenomi outlines anticipated 2025 milestonesJanuary 16, 2025 | msn.comMetagenomi Expands Leadership and Showcases InnovationsJanuary 16, 2025 | tipranks.comMetagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated MilestonesJanuary 16, 2025 | globenewswire.comMetagenomi appoints Eric Bjerkholt to board of directorsJanuary 16, 2025 | markets.businessinsider.com Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Email Address MGX Media Mentions By Week MGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGX News Sentiment▼0.000.56▲Average Medical News Sentiment MGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGX Articles This Week▼06▲MGX Articles Average Week Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Moderna News Today ProQR Therapeutics News Today Nanobiotix News Today Y-mAbs Therapeutics News Today I-Mab News Today Cardiff Oncology News Today Inhibrx Biosciences News Today MediWound News Today SOPHiA GENETICS News Today Monopar Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGX) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metagenomi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
